Shabir Ahmad

Mr. Shabir Ahmad

Abdul Wali Khan University Mardan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
Sudais RahmanSudais Rahman
Sudais Rahman
CCChien-Chun Chiou
Chien-Chun Chiou
SAShabir Ahmad
Shabir Ahmad
ZIZia-ul Islam
Zia-ul Islam
Tetsuya TanakaTetsuya Tanaka
Tetsuya Tanaka
AAAbid Ali
Abid Ali
Bartonella henselae is a Gram-negative bacterium causing a variety of clinical symptoms, ranging from cat-scratch disease to severe systemic infections, and it is primarily transmitted by infected fleas. Its status as an emerging zoonotic pathogen and its capacity to persist within host erythrocytes and endothelial cells emphasize its clinical significance. Despite progress in understanding its pathogenesis, limited knowledge exists about the virulence factors and regulatory mechanisms specific to the B. henselae strain Houston-1. Exploring these aspects is crucial for targeted therapeutic strategies against this versatile pathogen. Using reverse-vaccinology-based subtractive proteomics, this research aimed to identify the most antigenic proteins for formulating a multi-epitope vaccine against the B. henselae strain Houston-1. One crucial virulent and antigenic protein, the PAS domain-containing sensor histidine kinase protein, was identified. Subsequently, the identification of B-cell and T-cell epitopes for the specified protein was carried out and the evaluated epitopes were checked for their antigenicity, allergenicity, solubility, MHC binding capability, and toxicity. The filtered epitopes were merged using linkers and an adjuvant to create a multi-epitope vaccine construct. The structure was then refined, with 92.3% of amino acids falling within the allowed regions. Docking of the human receptor (TLR4) with the vaccine construct was performed and demonstrated a binding energy of −1047.2 Kcal/mol with more interactions. Molecular dynamic simulations confirmed the stability of this docked complex, emphasizing the conformation and interactions between the molecules. Further experimental validation is necessary to evaluate its effectiveness against B. henselae.

7 September 2020 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
AAAbid Ali
Abid Ali
SAShabir Ahmad
Shabir Ahmad
AWAbdul Wadood
Abdul Wadood
ARAshfaq U. Rehman
Ashfaq U. Rehman
HZHafsa Zahid
Hafsa Zahid
Abdulaziz AlouffiAbdulaziz Alouffi
Abdulaziz Alouffi
Ticks and tick-borne pathogens (TBPs) continuously causing substantial losses to the public and veterinary health sectors. The identification of putative drug targets and vaccine candidates is crucial to control TBPs. No information has been recorded on designing novel drug targets and vaccine candidates based on proteins. Subtractive proteomics is an in silico approach that utilizes extensive screening for the identification of novel drug targets or vaccine candidates based on the determination of potential target proteins available in a pathogen proteome that may be used effectively to control diseases caused by these infectious agents. The present study aimed to investigate novel drug targets and vaccine candidates by utilizing subtractive proteomics to scan the available proteomes of TBPs and predict essential and non-host homologous proteins required for the survival of these diseases causing agents. Subtractive proteome analysis revealed a list of fifteen essential, non-host homologous, and unique metabolic proteins in the complete proteome of selected pathogens. Among these therapeutic target proteins, three were excluded due to the presence in host gut metagenome, eleven were found to be highly potential drug targets, while only one was found as a potential vaccine candidate against TBPs. The present study may provide a foundation to design potential drug targets and vaccine candidates for the effective control of infections caused by TBPs.

22 December 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
AAAbid Ali
Abid Ali
SAShabir Ahmad
Shabir Ahmad
PAPedro Machado Medeiros de Albuquerque
Pedro Machado Medeiros de Albuquerque
AKAtif Kamil
Atif Kamil
FAFahdah Ayed Alshammari
Fahdah Ayed Alshammari
Itabajara da Silva Vaz JuniorItabajara da Silva Vaz Junior
Itabajara da Silva Vaz Junior
The emergence of drug-resistant lice, acari, and their associated pathogens (APs) is associated with economic losses; thus, it is essential to find new appropriate therapeutic approaches. In the present study, a subtractive proteomics approach was used to predict suitable therapeutics against these vectors and their infectious agents. We found 9701 proteins in the lice (Pediculus humanus var. corporis) and acari (Ixodes scapularis, Leptotrombidium deliense), and 4822 proteins in the proteomes of their APs (Babesia microti, Borreliella mayonii, Borrelia miyamotoi, Borrelia recurrentis, Rickettsia prowazekii, Orientia tsutsugamushi str. Boryong) that were non-homologous to host proteins. Among these non-homologous proteins, 365 proteins of lice and acari, and 630 proteins of APs, were predicted as essential proteins. Twelve unique essential proteins were predicted to be involved in four unique metabolic pathways of lice and acari, and 103 unique proteins were found to be involved in 75 unique metabolic pathways of APs. The sub cellular localization analysis of 115 unique essential proteins of lice and acari and their APs revealed that 61 proteins were cytoplasmic, 42 as membrane-bound proteins and 12 proteins with multiple localization. The druggability analysis of the identified 73 cytoplasmic and multiple localization essential proteins revealed 22 druggable targets and 51 novel drug targets that participate in unique pathways of lice and acari and their APs. Further, the predicted 42 membrane bound proteins could be potential vaccine candidates. Screening of useful inhibitors against these novel targets may result in finding novel compounds efficient for the control of these parasites.

20 October 2020 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
AAAbid Ali
Abid Ali
SAShabir Ahmad
Shabir Ahmad
AWAbdul Wadood
Abdul Wadood
ARAshfaq U. Rehman
Ashfaq U. Rehman
HZHafsa Zahid
Hafsa Zahid
Abdulaziz AlouffiAbdulaziz Alouffi
Abdulaziz Alouffi
The authors wish to make the following corrections to this paper